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1. Introduction 
Allergic rhinitis (AR) is one of the most common allergic diseases, affecting 20% of the adult 
population and up to 40% of children (Salib et al., 2003). It is associated with decreased 
learning, performance and productivity at work and school, as well as a reduced quality of 
life. The detrimental effects of AR on quality of life (QOL) include fatigue, irritability, 
memory deficits, excessive daytime somnolence, and depression. The annual economic 
impact of AR is calculated to be between $ 6.3 billion and $ 7.9 billion without counting its 
detrimental effects on QOL (Fineman, 2002). Current therapeutic options such as allergen 
avoidance, medication and immunotherapy are far from ideal. It is important to develop an 
effective modality to relieve the symptom except for targeting the complexity of underlying 
inflammatory mechanism of AR. 
Phototherapy is the application of light to a pathological area to promote tissue regeneration, 
reduce inflammation and relieve pain. Several types of phototherapeutic devices are currently 
used for medical treatment using selected wavelengths and controlled dosage of irradiation. 
Significant suppression on the clinical symptoms of AR by the phototherapy treatment of 
ultraviolet (UV) and visible light was reported (Csoma, et al., 2004, 2006; Koreck, et al., 2005, 
2007). Narrow-band red light phototherapy was found to markedly alleviate the clinical 
symptoms of AR (Neuman & Finkelstein, 1997). In addition to UV and visible light therapy, 
far infrared ray (FIR) therapy is also reported to have beneficial effects to patients with AR (Hu 
& Li, 2007). Photochemical effect is elicited using UV and visible light irradiation, whereas 
thermal effect is induced with FIR irradiation. Although different mechanisms are involved 
when light sources with different ranges of wavelengths are employed, phototherapy 
represents a noninvasive, alternative intervention for the treatment of AR. 
This chapter is organized as follows. First, pathophysiology and traditional management of 
AR are briefly reviewed. Second, photobiology and phototherapy related to AR are 
summarized. Finally, the clinical outcomes of FIR therapy as well as red light acupoint 
stimulation on patients with AR are described. 
2. Pathophysiology of allergic rhinitis 
AR is defined as an abnormal inflammation of the membrane lining the nose, which is 
mediated by immunoglobulin E (IgE). The clinical symptoms of AR include sneezing, 
www.intechopen.com
 
Allergic Rhinitis 
 
184 
itching of the nose, rhinorrhea and nasal congestion. Additionally, airway lining 
hypersensitivity, a loss of the sense of small and an inability to taste may occur. It has 
become progressively clear that it is a common comorbid condition with asthma, allergic 
conjunctivitis, sinusitis, otitis media, nasal polyposis and respiratory infections (Berrettini, et 
al., 1999; Skoner, 2000). Nasal obstruction can often be seen with pale nasal mucosa, 
enlarged turbinates, clear nasal secretions, and pharyngeal cobble-stoning upon physical 
examination (Al Suleimani & Walker, 2007). The diagnosis of AR was based on definite 
symptoms of nasal itching, rhinorrhea, sneezing, nasal obstruction or mouth breathing, as 
well as positive reactions to blood tests to antigens, such as house dust mite, cockroach, 
molds, feathers, grass pollen, weed pollens, sage pollen, and local tree pollens, etc. Criteria 
for positive skin prick test responses were a wheel of 3 mm or greater diameter with 
erythema of at least 5 mm. Histamine control skin test was read at 10 minutes, allergen and 
negative control skin tests were read at 15 minutes. The score for each symptom is usually 
registered on a four-grade scale- absent, slight, moderate or severe (Linder, 1988) as shown 
in Table 1. 
 
Scoring of eye itching 
0: no eye itching 
1: rubbing eyes less than 5 episodes a day 
2: rubbing eyes 6-10 episodes a day 
3: rubbing eyes more than 10 episodes a day 
Scoring of rhinorrhea 
0: no nasal blowing 
1:nasal blowing less than 5 episodes a day 
2: nasal blowing 6-10 episodes a day 
3: nasal blowing more than 10 episodes a 
day 
Scoring of nasal itching 
0: no nasal itching  
1: rubbing nose less than 5 episodes a day 
2: rubbing nose 6-10 episodes a day 
3: rubbing nose more than 10 episodes a day
Scoring of smell impairment 
0: no smell impairment 
1: hyposmia with mild smell impairment 
2: hyposmia with moderate smell 
impairment 
3: anosmia 
Scoring of nasal stuffiness 
0: no nasal stuffiness 
1: nasal stuffiness without mouth breathing 
2: nasal stuffiness with sporadic mouth 
breathing 
3: nasal stuffiness with predominant mouth 
breathing 
Scoring of sneezing 
0: no sneezing 
1: sneezing less than 5 episodes a day 
2: sneezing 6-10 episodes a day 
3: sneezing more than 10 episodes a day 
Table 1. Scoring of symptoms for AR 
Various mediators are associated to the pathophysiology of AR. For example, histamine 
plays a pivotal role in early allergic responses and also acts as stimulatory signal for 
cytokine production, expression of cell adhesion molecules and HLA class II antigens. Most 
of the effects of histamine in allergic disease are mediated through H1 receptors (Akdis & 
Blaser, 2003). Cysteinyl leukotrienes (CysLTs) increase nasal airway resistance and 
obstruction, and contribute to rhinorrhea via increased vascular permeability and mucus 
secretion (Okuda, et al., 1988). Prostaglandins cause congestion and rhinorrhea. 
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Neuropeptides induce vasodilation, thus causing congestion (Howarth, 1997). Cytokine 
secretion upregulates the expression of adhesion molecules on the vascular endothelial cells, 
thereby enhancing the activation and adhesion of inflammatory cells. An increase in 
interleukin-4 (IL-4), IL-5, and granulocyte-macrophage colony-stimulating factor (GM-CSF) 
is associated with a mucosal eosinophilia (Quraishi, et al., 2004). 
3. Traditional management of allergic rhinitis 
Effective allergen avoidance can lead to substantial relief of symptoms. However, patients 
are still not able to avoid their confirmed allergens such as mites or atmospheric pollens 
under many circumstances. Medication to manipulate the release of mediators is the next 
step in the management of AR. Table 2 summarizes the classes of pharmacological therapies 
for the treatment of AR. The two major classes of medication are oral H1 antihistamines and 
intranasal corticosteroids. According to the guidelines, oral antihistamines are the first-line 
therapy which relieve sneezing and rhinorrhea (Bousquet, et al., 2001; van Cauwenberge, et 
al., 2000; Dykewicz, et al., 1998). Topical administration can further minimize systemic 
adverse effects of antihistamines. H1 antihistamines are often combined with a decongestant 
to reach sufficient efficacy for nasal congestion (Quraishi, et al., 2004). The new generation of 
antihistamines acts as inverse agonists that stabilize the inactive conformation of the 
receptors and reverses constitutive activity of receptors (Oppenheimer & Casale, 2002). 
Intranasal corticosteroids are recommended as first-line treatment for moderate and severe 
AR, which are effective in relieving symptoms such as sneezing, rhinorrhea, itching and 
congestion (Weiner, et al., 1998). Corticosteroids target the inflammatory mechanisms; 
therefore the amount of oral corticosteroids for long-term treatment should be carefully 
adjusted to avoid adverse effects such as osteoporosis and growth inhibition in children 
(Wilson, et al., 1998). 
Decongestants can reduce nasal obstruction and congestion by their vasoconstrictive action 
on ǂ-adrenergic receptors. The application of intranasal decongestants may cause rhinitis 
medicamentosa. The adverse effects of oral decongestants include elevated blood pressure, 
tremor, tachycardia, loss of appetite, sleep disturbance. The long term use of decongestant is 
not recommended. (Quraishi, et al., 2004). Anticholinergics act as muscarinic receptor 
blocker which inhibits mucus secretion and subsequent rhinorrhea. Through inhibiting 
degranulation and neosynthesis of inflammatory mediators, mast cell stabilizers are shown 
to be effective in reducing symptoms of early inflammatory phase and are useful for 
preventive purposes (Al Suleimani & Walker, 2007). Leukotrienes inhibitors significantly 
reduce nasal blockade by inhibiting leukotriene synthesis or serving as antagonists for its 
receptors. Immunotherapy has the potential to provide a permanent cure for the disease. 
The proposed mechanisms for immunotherapy include suppression of IgE elevation, 
decrease in neutrophil and eosionophil activity, reduction in mast cell number, inhibition of 
T-lymphocyte proliferation (Jayasekera, et al., 2007; Pipet, et al., 2009). However, the 
technique is burdensome which requiring a lengthy series of injection and it may not be 
applicable to all patients (Naclerio, et al., 2002). Although most of the drugs are effective in 
treating certain symptoms of AR, they all have limitations due to their adverse effects. Due 
to the complex mechanisms involved in the AR, the ideal treatment for this disease has yet 
to be discovered. 
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Class 
Route of 
administrati
-on 
Mechanism of action 
Symptom 
relief 
Adverse effects 
Antihistami-
nes 
Intranasal, 
oral 
Antagonists or inverse 
agonists for histamine 
at the histamine 
receptor 
Sneezing, 
rhinorrhea, 
itching 
First-generation: 
sedation, impaired 
mental performance, 
dry mouth, dry eyes, 
urinary retention 
Corticostero-
ids 
Intranasal, 
oral 
Bind to glucocorticoid 
receptors, affecting the 
production of various 
mediators 
Sneezing, 
rhinorrhea, 
itching, 
congestion 
Intranasal: nose 
irritation, bleeding 
Oral: long-term use 
may cause growth 
inhibition in children 
and osteoporosis 
Decongestants 
Intranasal, 
oral 
Stimulate ǂ-
adrenergic receptors 
to induce 
vasoconstriction 
Congestion 
Intranasal: rhinitis 
medicamentosa 
Oral: elevated blood 
pressure, tremor, 
tachycardia, loss of 
appetite, sleep 
disturbance 
Anticholinerg
-ics 
Intranasal 
Muscarinic receptor 
blockade 
Rhinorrhea Minimal 
Mast cell 
stabilizers 
Intranasal 
Prevent mast cell 
degranulation and 
neosynthesis of 
inflammatory 
mediators 
Sneezing, 
rhinorrhea, 
itching, 
congestion 
Minimal 
Leukotriene 
inhibitors 
Oral 
Leukotriene synthesis 
inhibitors, antagonists 
for the leukotriene 
receptors 
Sneezing, 
rhinorrhea, 
congestion 
Possibility of 
neuropsychiatric side 
effects 
Immunothera-
py 
Subcutaneo-
us injection 
Suppress IgE 
elevation, neutrophil 
and eosionophil 
activity, mast cell 
number, T-
lymphocyte 
proliferation 
Early or late 
inflammatory 
phase 
responses 
Unknown effects 
from the modification 
of immune system 
Table 2. Current therapeutic agents in use for AR 
www.intechopen.com
 
 
Phototherapy for the Treatment of Allergic Rhinitis 
 
187 
4. Photobiology 
Electromagnetic radiation comprises of radio, microwave, infrared (IR), visible light, UV, X-
ray and gamma radiation. The phenomenon of light absorption to produce electronic 
excitation of atoms and molecules has long been accepted by photochemists and 
photobiologists. In phototherapy, wavelengths used include UV (100-400 nm), visible light 
(400-800 nm) and IR (800-105 nm). 
Photobiological reactions often involve the absorption of a specific wavelength of light by 
the functioning photoacceptor molecule. Photochemical effect is elicited using UV and 
visible light irradiation, whereas thermal effect is induced with FIR irradiation. Light in the 
ultraviolet range is absorbed by the protein part of the molecule and the visible and NIR 
wavelengths are absorbed by the metals. Further analysis of action spectra, it is suggested 
that the primary photoacceptor for the red-NIR wavelengths in mammalian cells is 
cytochrome c oxidase in terminal respiratory chain (Karu, et al., 2005, 2008). Flavoproteins 
such as NADH dehydrogenase in the beginning of the respiratory chain is believed to be the 
photoacceptor for the violet-to-blue spectral range (Karu, 2003). In addition, light induces a 
wave-like alternating electric field in a medium that is able to interact with polar structures 
and produce dipole transitions. These dipole transitions may lead to the primary actions at 
cellular and biochemical levels (Amat, et al., 2006). 
Early hypothesis of the mechanism of primary action upon visible light irradiation can be 
divided into two categories: (1) singlet oxygen hypothesis based on the singlet oxygen 
generation from the endogenous molecules possessing the properties of photosensitizers, 
such as porphyrins and flavoproteins, upon irradiation (Vladimirov, et al., 2004), and (2) the 
oxidation-reduction hypothesis based on the excitation in chromophores of cytochrome-
oxidase complex such as CuA, CuB or heme a(a3), thereby enhancing the electron transfer rate 
(Lubart, et al., 2005). Later, the nitric oxide (NO) hypothesis was proposed suggesting that 
the activity of cytochrome c oxidase can be regulated by NO, here light irradiation can 
reverse the partial inhibition by NO (Karu, et al., 2005). Superoxide anion hypothesis was 
also suggested because of increased production of superoxide anion by irradiation, possibly 
through promoting the mitochondrial respiratory chain (Karu, 2003). The transient local 
heating hypothesis suggested that the irradiation energy may lead to a local transient 
increase in the temperature of absorbing chromophores, which may cause structural 
changes and trigger biochemical activity (Hallen, et al., 1993). The primary reactions upon 
light irradiation mainly occur in the mitochondria, which may lead to the secondary 
reactions occurring in the nucleus and cytoplasm. The secondary reactions involves cellular 
signaling cascade including increased intracellular ATP level, activation of transcription 
factors such as Nuclear factor-kappa B (NF-κB) and AP-1, activation of NADPH oxidase, 
change of the cellular redox potential to more oxidized direction (increased ROS 
production), manipulation of Ca2+ concentration, alteration of mitochondrial 
transmembrane potential (ΔΨm), regulation of inducible nitric oxide synthase (iNOS) 
activity and intracellular pH, and increased DNA/RNA synthesis (Karu, 2003). Other 
phenomena such as suppression of inflammatory cytokines, up-regulation of growth factor 
production, modification of extracellular matrix components, inhibition of apoptosis, 
stimulation of mast cell degranulation, and up-regulation of heat shock protein are also 
observed (Lin, et al., 2010). 
IR are invisible electromagnetic waves which are subdivided into three categories: near-
infrared (NIR) (0.8-1.5 μm), middle-infrared (1.5-5.6 μm) and far-infrared (FIR) (5.6-1000 
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μm). Different photobiological mechanisms are involved when FIR radiation is employed in 
phototherapy. The main principles of FIR are radiation, deep penetration and absorption of 
resonance. At molecular level, FIR exerts rotational and vibrational effects that are 
biologically beneficial. FIR therapy is often used as alternative physical therapy to decrease 
joint stiffness, relieve muscle spasms, assist soft tissue injury repair, lead to pain relief, and 
help to resolve inflammatory infiltrated edema. FIR therapy can improve blood flow and 
survival of the arteriovenous fistula in hemodialysis patients (Lin, et al., 2007). Furthermore, 
FIR stimulation on acupoints at Qihai, Kuan yuan and Chung chi decreases both stress and 
fatigue levels as well as stimulates autonomic nervous system activity in hemodialysis 
patients (Su, et al., 2009). IR radiation is believed to transfer energy that is perceived as heat 
by thermoreceptors in the surrounding skin (Inoué & Kabaya, 1989). The abdominal skin 
temperature steadily increased to a plateau between 38 and 39oC when the top FIR radiator 
was 20 cm above the rats (Yu, et al., 2006). The expression of HSP70 participates in 
cytoprotection and may be induced by hyperthermia, infection, UV radiation, NO, etc. 
However, an in vitro study demonstrated that FIR radiation inhibited the proliferation of 
cancer cells by the low expression level of heat shock protein 70A (Ishibashi, et al., 2008). In 
addition to the thermal effect, the non-thermal biological effects of FIR therapy led to 
enhance the extensibility of collagen tissue, stimulate the secretion of transforming growth 
factor-ǃ1, and increase microcirculation via L-arginine/NO pathway (Toyokawa, et al., 2003; 
Yu, et al., 2006). Repeated FIR therapy could upregulate the expression of endothelial NO 
synthase (eNOS) (Akasaki, et al., 2006). FIR therapy was found to exert an anti-
inflammatory effect via the induction of heme oxygenase-1 in endothelial cells via 
stimulating NF-E2-related factor (Nrf2) dependent promoter activity. TNF--induced 
expression of E-selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular cell 
adhesion molecule-1 (ICAM-1) were suppressed (Lin, et al., 2008). A study on the 
mechanism of action demonstrated that FIR radiation activated p38 and extracellular signal-
regulated kinase (ERK), but not Akt or c-Jun N-terminal protein kinases (JNK), and 
significantly promoted angiogenesis by increasing tube formation and the migration of 
endothelial cells (Rau, et al., 2010). Based on the above studies, the mechanism of action by 
FIR therapy can be both thermal and non-thermal effects. 
5. Phototherapy in allergic rhinitis 
Phototherapy is an effective treatment modality in inflammatory and immue mediated 
dieases. It has been successfully used in dermatology practice for several decades. The XeCl 
UV-B laser irradiation and mixed irradiation with UV-A (25%), UV-B (5%) and visible light 
(70%) (mUV/VIS) resulted in a dose-dependent inhibition of the allergen-induced wheal 
formation on the skin (Cosma, et al., 2004; Koreck, et al., 2004). Development of new 
phototherapeutic devices made it possible to treat the inflammatory disease of the nasal 
mucosa. Intranasal UV-B phototherapy with medium-dose 308 nm XeCl excimer 
significantly suppressed the nsasl symptoms of patients with severe hay fever (Cosma, et al., 
2004). Rhinophototherapy consist of using mUV/VIS resulted in a significant improvement 
of clinical symptoms for sneezing, rhinorrhea, nasal itching, and total nasal score (Koreck, et 
al., 2005). The number of eosinophils and the level of eosinophil cationic protein and IL-5 
were also reduced. Statiscally significant differences were found in the average results of the 
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Rhinoconjunctivitis Quality of Life Questionnaire (Cingi, et al., 2009). Another prospective, 
randomized, single-blind study showed that total nasal scores decreased in both mUV/VIS 
and low-intensity visible light (mUV/VIS without UV) treated groups (Cingi, et al., 2010). 
But the decrease was highly significant in the mUV/VIS treated group when compared with 
the low-intensity visible light treated group. However, the impact of endonasal 
phototherapy on the number of Langerhans cells in the nasal mucosa was limited (Brehmer 
& Schön, 2010). DNA damage was significantly higher in nasal cytology samples collected 
immediately after the last treatment (Koreck, et al., 2007). The DNA damage induced by 
intranasal UV phototherapy was efficiently repaired two months after ending therapy. One 
of the possible mechanisms that explain the immunosuppressive effect of mUV/VIS is the 
induction of apoptosis of T cells and eosinophils after UV damage, thus, leading to the 
inhibition of synthesis and release of pro-inflammatory mediators (Kemény & Koreck, 2007). 
The side effect of phototherapy is dryness of nasal mucosa, which can be overcome with 
emollients. Another disadvantage of UV-B treatment is the risk of carcinogenesis. Therefore, 
it is important to develop phototherapeutic devices using wavelengths other than UV 
(Morita, et al., 2008). 
Very few papers report the application of the light in the other wavelengths in addition to 
UV light for the management of AR despite that over 2500 papers have been published 
regarding low level light therapy as a therapeutic modality to speed up tissue repair as well 
as related biochemical, cellular, histological and functional effects. NIR irradiation 
suppressed contact hypersensitivity reaction in rats via systemic immunomodulatory effect 
(Kandolf-Sekulovic, et al., 2003). A double-blind randomized study showed that 70% 
improvement of clinical symptoms on AR after intranasal illumination at 660 nm (Neuman 
& Finkelstein, 1997). Thus, light in red or NIR wavelengths with different mechanism of 
action from UV and visible light may be an ideal candidate for the intervention of AR after 
systematic study. 
5.1 Far infrared irradiation in allergic rhinitis 
FIR therapy, a non-invasive and convenient therapeutic modality, can improve blood flow 
and inflammatory status through both its thermal and non-thermal effects. By applying 
FIR therapy to the nasal region in the patients with AR, our study demonstrated that FIR 
therapy could improve significantly for the clinical symptoms of eye itching, nasal 
itching, nasal stuffiness, rhinorrhea and sneezing during period of therapy (Hu & Li, 
2007). 
Thirty-one patients with perennial AR enrolled in the study completed the FIR therapy. All 
patients had daily symptoms despite antihistamines and local steroid spray treatments. 
Patients with severe deviation of the nasal septum causing bilateral nasal obstruction and 
suffering from sinusitis were excluded from the study. A FIR emitter was used for FIR 
therapy in this study. The wavelength of the light generated from the electrified ceramic 
plates of this emitter was in the range between 5 and 12 μm with a peak at 8.2 μm. The 
radiator was positioned via facing patient’s nasal region at a distance of 30 cm. The 
therapeutic time was 40 minutes everyday for 7 days. All the FIR therapies were performed 
in the morning between 9 am and noon. During the course of the study, the patients did not 
receive any other anti-allergic management. The effects of FIR on the clinical symptoms 
were analyzed by the paired sample t-test. 
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Fig. 1. Mean values of daily scores for six symptoms of AR. The score is given on a scale 
from 0 = no symptom to 3 = severe symptom. The symptom scores decreased over the 
period of FIR treatment. Pre-treatment (Day 0); during treatment (Day 1-7). 
Mean values of daily registrations for eye itching, nasal itching, nasal stuffiness, rhinorrhea, 
smell impairment and sneezing after FIR therapy are given in Figure 1. All the symptom 
scores were reduced by more than 50% by the end of the FIR therapy. The most severe 
symptom of the pre-treat patients was rhinorrhea, which the mean value of the symptom 
score was 2.26, followed by sneezing and nasal stuffiness with scores of 1.94 and 1.84, 
respectively. The least severe symptom of the pre-treat patients was smell impairment with 
a mean score of 0.61. After the one-week treatment period, significant improvements were 
observed in all the symptoms of AR patients. The improved clinical symptoms were usually 
seen 1 day after the start of therapy, and thereafter the improvement was continuous. 
However, the smell impairment did not reveal significant improvement until after the 7th 
therapy. This was probably because the pre-treatment score of smell impairment was only 
0.61 and not much room for improvement of the score or FIR was not very effective on 
improving olfactory disorder. 
Our study demonstrated the improving effect of FIR therapy on the clinical symptoms of 
AR. Most of the clinical symptoms improved quickly and significantly. The patients 
tolerated the treatment well, and no severe adverse effect was observed during FIR 
treatment. 
5.2 Red light acupoint stimulation in allergic rhinitis 
Acupuncture involves the stimulation of acupoints that are located at a lines of meridians 
that correspond to the flow of energy through the body. Traditional treatment for AR by 
acupuncture may include needling and moxibustion. Modern acupuncture has evolved 
other methods of stimulating acupoints including the use of an electrical current, by 
applying pressure to the acupoint (acupressure) or using a low intensity laser or light 
emitting diodes (LEDs). Evidence suggests that acupuncture is a useful complementary or 
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alternative treatment option for AR in both adults and children (Xue, et al., 2002; Ng, et al., 
2004). Points of the ear are sensitive acupuncture treatment sites for a range of clinical 
conditions. Ear-acupressure is commonly used as a non-invasive alternative stimulation 
method by using small seeds or metal pellets on ear acupoints. A review based on 92 
research papers searched from 21 electronic English and Chinese databases concluded that 
ear-acupressure was more effective than herbal medicine, as effective as body acupuncture 
or antihistamine for short-term effect. But it was more effective than anti-histamine for long-
term effect. However, the benefit of ear-acupressure for systematic relief of AR is unknown 
due to the poor quality of included studies (Zhang, et al., 2010). 
Allergic symptoms are largely dependent on oxygen radical formation, which were found to 
be suppressed after red light illumination. Shangyingxiāng Xue is an acupoint at the upper 
end of nasolabial fold. Acupuncture to Shangyingxiāng Xue helps to relieve symptoms of 
AR, rhinorrhea with turbid discharge, stuffy nose, and headache. Here, we evaluated the 
clinical effects of phototherapy using red light to Shangyingxiāng Xue on patients with 
AR(Hu & Yan, 2009). 
Sixty-one AR patients who met the inclusion criteria were enrolled in this study. Patients 
were divided randomly into the treating group and control group. All patients filled out the 
informed consent form before treatment and recorded their symptom scores everyday in a 
diary before and during treatment. Thirty-one patients in the treating group received 
phototherapy with LEDs consisted of two wavelengths, 660 and 850 nm, to bilateral 
Shangyingxiāng Xue. Phototherapy was performed once a day for 7 days. The duration of 
each treatment was 10 minutes. Thirty patients in the control group received antihistamine 
(Zyrtec, 10 mg) once a day for 7 days. A symptom score of 0 to 3 was assigned for each of 
the following rhinitis symptoms: eye itching, nasal itching, nasal obstruction, rhinorrhea, 
smell impairment, sneezing and size of inferior turbinate. The scores of pre- and post-
therapy in both groups were collected after the course of treatments and analyzed by using 
the paired sample t-test. 
 Thirty-one patients enrolled in the study completed the red light phototherapy. Mean 
values of daily registrations for eye itching, nasal itching, nasal stuffiness, rhinorrhea, smell 
impairment and sneezing are given in Figure 2. Most of the symptoms were quickly and 
significantly improved. The most severe symptom of the pre-treat patients was rhinorrhea, 
which the mean value of the symptom score was 2.0, followed by sneezing and nasal 
stuffiness with scores of 1.84 and 1.55, respectively. The least severe symptom of the pre-
treat patients was smell impairment with a mean score of 0.71. After the one-week treatment 
period, significant improvements were observed in all the symptoms of AR patients. The 
improved clinical symptoms were usually seen 1 to 2 days after the start of therapy, and 
thereafter the improvement was continuous. However, the smell impairment did not reveal 
significant improvement until after the third treatment. This was probably because the pre-
treatment score was lower than the others that there was not much room for improvement 
or phtotherapy to acupoint was not so effective on improving olfactory disorder. 
Comparing the clinical effects of phototherapy and antihistamine control groups with 
repeated measures analysis, no difference was observed except the size of inferior turbinate. 
To sum up, phototherapy to Shangyingxiāng Xue could relieve the symptoms. Its low cost 
and low side effect suggest that phototherapy to Shangyingxiāng Xue is an attractive 
alternative to conventional treatment for AR patients. 
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Fig. 2. Mean values of daily scores for symptoms of experimental group by using red light 
phototherapy. The symptom scores decreased over the period of red light treatment. Pre-
treatment (Day 0); during treatment (Day 1-7). 
6. Conclusion 
Although new medication and topical applications are used with good results in the 
management of AR, there are cases in which complete resolution of symptoms cannot be 
obtained. Moreover, the use of drugs is not suitable for pregnant and breast-feeding women. 
Phototherapy is a safe and promising therapeutic modality for AR. Accumulating evidence 
supports that phototherapy suppresses the effector phase and results in significant 
improvement of clinical symptoms of AR. By applying FIR therapy to the nasal region in the 
patients with AR, our study demonstrated that FIR therapy could improve the clinical 
symptoms of eye itching, nasal itching, nasal stuffiness, rhinorrhea and sneezing 
significantly during period of therapy. Employing phototherapy to bilateral Shangyingxiāng 
Xue (an acupoint at the upper end of nasolabial fold) at 660 and 850 nm, symptom scores of 
AR had all significantly decreased in the treating group. In addition to UV and visible light, 
phototherapy with FIR and red light irradiation can improve the symptoms of AR and may 
serve as a novel modality in the treatment of AR. 
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